355 related articles for article (PubMed ID: 31780963)
21. Hoarding symptoms and prediction of poor response to limbic system surgery for treatment-refractory obsessive-compulsive disorder.
Gentil AF; Lopes AC; Dougherty DD; Rück C; Mataix-Cols D; Lukacs TL; Canteras MM; Eskandar EN; Larsson KJ; Hoexter MQ; Batistuzzo MC; Greenberg BD; Miguel EC
J Neurosurg; 2014 Jul; 121(1):123-30. PubMed ID: 24702323
[TBL] [Abstract][Full Text] [Related]
22. Convergent and discriminant validity of the Yale-Brown Obsessive-Compulsive Scale Symptom Checklist.
Mataix-Cols D; Fullana MA; Alonso P; Menchón JM; Vallejo J
Psychother Psychosom; 2004; 73(3):190-6. PubMed ID: 15031592
[TBL] [Abstract][Full Text] [Related]
23. A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorder.
Denys D; van Megen HJ; van der Wee N; Westenberg HG
J Clin Psychiatry; 2004 Jan; 65(1):37-43. PubMed ID: 14744166
[TBL] [Abstract][Full Text] [Related]
24. Duloxetine Augmentation in Resistant Obsessive-Compulsive Disorder: A Double-Blind Controlled Clinical Trial.
Mowla A; Boostani S; Dastgheib SA
J Clin Psychopharmacol; 2016 Dec; 36(6):720-723. PubMed ID: 27811556
[TBL] [Abstract][Full Text] [Related]
25. Psychometric analysis of the Yale-Brown Obsessive-Compulsive Scale Second Edition Symptom Checklist.
Storch EA; Larson MJ; Price LH; Rasmussen SA; Murphy TK; Goodman WK
J Anxiety Disord; 2010 Aug; 24(6):650-6. PubMed ID: 20471199
[TBL] [Abstract][Full Text] [Related]
26. Results of Gamma Knife anterior capsulotomy for refractory obsessive-compulsive disorder: results in a series of 10 consecutive patients.
Spatola G; Martinez-Alvarez R; Martínez-Moreno N; Rey G; Linera J; Rios-Lago M; Sanz M; Gutiérrez J; Vidal P; Richieri R; Régis J
J Neurosurg; 2018 Sep; 131(2):376-383. PubMed ID: 30215566
[TBL] [Abstract][Full Text] [Related]
27. Gamma ventral capsulotomy for obsessive-compulsive disorder: a randomized clinical trial.
Lopes AC; Greenberg BD; Canteras MM; Batistuzzo MC; Hoexter MQ; Gentil AF; Pereira CA; Joaquim MA; de Mathis ME; D'Alcante CC; Taub A; de Castro DG; Tokeshi L; Sampaio LA; Leite CC; Shavitt RG; Diniz JB; Busatto G; Norén G; Rasmussen SA; Miguel EC
JAMA Psychiatry; 2014 Sep; 71(9):1066-76. PubMed ID: 25054836
[TBL] [Abstract][Full Text] [Related]
28. Predicting the therapeutic response to cognitive behavioural therapy in patients with pharmacoresistant obsessive-compulsive disorder.
Prasko J; Raszka M; Adamcova K; Grambal A; Koprivova J; Kudrnovská H; Latalova K; Vyskocilová J
Neuro Endocrinol Lett; 2009; 30(5):615-23. PubMed ID: 20035255
[TBL] [Abstract][Full Text] [Related]
29. Congruence and discrepancy between self-rated and clinician-rated symptom severity on the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) before and after a low-intensity intervention.
Hauschildt M; Dar R; Schröder J; Moritz S
Psychiatry Res; 2019 Mar; 273():595-602. PubMed ID: 30716599
[TBL] [Abstract][Full Text] [Related]
30. Treatment response, symptom remission, and wellness in obsessive-compulsive disorder.
Farris SG; McLean CP; Van Meter PE; Simpson HB; Foa EB
J Clin Psychiatry; 2013 Jul; 74(7):685-90. PubMed ID: 23945445
[TBL] [Abstract][Full Text] [Related]
31. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions.
Rosario-Campos MC; Miguel EC; Quatrano S; Chacon P; Ferrao Y; Findley D; Katsovich L; Scahill L; King RA; Woody SR; Tolin D; Hollander E; Kano Y; Leckman JF
Mol Psychiatry; 2006 May; 11(5):495-504. PubMed ID: 16432526
[TBL] [Abstract][Full Text] [Related]
32. Concurrent validity of the Yale-Brown Obsessive-Compulsive Scale-Symptom Checklist.
Sulkowski ML; Storch EA; Geffken GR; Ricketts E; Murphy TK; Goodman WK
J Clin Psychol; 2008 Dec; 64(12):1338-51. PubMed ID: 18942133
[TBL] [Abstract][Full Text] [Related]
33. The safety and efficacy of transcranial direct current stimulation as add-on therapy to fluoxetine in obsessive-compulsive disorder: a randomized, double-blind, sham-controlled, clinical trial.
Yoosefee S; Amanat M; Salehi M; Mousavi SV; Behzadmanesh J; Safary V; Yoonesi A; Salehi B
BMC Psychiatry; 2020 Nov; 20(1):570. PubMed ID: 33256659
[TBL] [Abstract][Full Text] [Related]
34. Defining clinical severity in adults with obsessive-compulsive disorder.
Storch EA; De Nadai AS; Conceição do Rosário M; Shavitt RG; Torres AR; Ferrão YA; Miguel EC; Lewin AB; Fontenelle LF
Compr Psychiatry; 2015 Nov; 63():30-5. PubMed ID: 26555489
[TBL] [Abstract][Full Text] [Related]
35. Intensive residential treatment for severe obsessive-compulsive disorder: characterizing treatment course and predictors of response.
Brennan BP; Lee C; Elias JA; Crosby JM; Mathes BM; Andre MC; Gironda CM; Pope HG; Jenike MA; Fitzmaurice GM; Hudson JI
J Psychiatr Res; 2014 Sep; 56():98-105. PubMed ID: 24909787
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and clinical predictors of response to rTMS treatment in pharmacoresistant obsessive-compulsive disorder (OCD): a retrospective study.
Rostami R; Kazemi R; Jabbari A; Madani AS; Rostami H; Taherpour MA; Molavi P; Jaafari N; Kuo MF; Vicario CM; Nitsche MA; Salehinejad MA
BMC Psychiatry; 2020 Jul; 20(1):372. PubMed ID: 32677923
[TBL] [Abstract][Full Text] [Related]
37. N-acetylcysteine add-on treatment in refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial.
Afshar H; Roohafza H; Mohammad-Beigi H; Haghighi M; Jahangard L; Shokouh P; Sadeghi M; Hafezian H
J Clin Psychopharmacol; 2012 Dec; 32(6):797-803. PubMed ID: 23131885
[TBL] [Abstract][Full Text] [Related]
38. Responsiveness and other psychometric properties of the Yale-Brown Obsessive-Compulsive Scale Severity Scale-Second Edition in a Dutch clinical sample.
Alić M; de Leeuw A; Selier J; van Megen H; Visser H
Clin Psychol Psychother; 2022 Jul; 29(4):1355-1363. PubMed ID: 35080071
[TBL] [Abstract][Full Text] [Related]
39. Granisetron adjunct to fluvoxamine for moderate to severe obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial.
Askari N; Moin M; Sanati M; Tajdini M; Hosseini SM; Modabbernia A; Najand B; Salimi S; Tabrizi M; Ashrafi M; Hajiaghaee R; Akhondzadeh S
CNS Drugs; 2012 Oct; 26(10):883-92. PubMed ID: 22873680
[TBL] [Abstract][Full Text] [Related]
40. Validation of the Italian version of the Yale-Brown Obsessive Compulsive Scale-Second Edition (Y-BOCS-II) in a clinical sample.
Melli G; Avallone E; Moulding R; Pinto A; Micheli E; Carraresi C
Compr Psychiatry; 2015 Jul; 60():86-92. PubMed ID: 25842194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
